To ensure the ongoing affordability of generic medications for Americans, BCBS is committing $55 million to establish a partnership with Civica Rx to reduce costs of generics for consumers.
The mechanisms of pharmaceutical rebates in Medicare Part D and commercial insurance.
Recent polling shows that 8 in 10 Americans believe that drug prices are “unreasonable,” and a majority think that taking action to lower prescription drug prices should be the top priority for Congress.
Recent pharmaceutical innovations offer unprecedented possibilities for curing, treating, or preventing a range of diseases. However, patients, providers and payers alike have raised concerns about the affordability and sustainability of these drugs.